Megane VERNON-CONTENTIN Ingénieur de recherche

Identifiants chercheurs

IdHAL :

megane-vernon

ORCID :

0000-0002-0953-6819

IdRef :

233097325

Publications

Article dans une revue (9)

Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study Jonaz Font,Amir Hodzic,Angélique Da-Silva,Baptiste Delapierre,Ghandi Damajet al. Biomedicines, 2025, 13 (9), pp.2184. ⟨10.3390/biomedicines13092184⟩ Article dans une revue hal-05411085v1
Lysosomal lipid peroxidation regulates tumor immunity Monika Bhardwaj,Jennifer J Lee,Amanda M Versace,Sandra L Harper,Aaron R Goldmanet al. The Journal of clinical investigation, 2023, 133 (8), ⟨10.1172/JCI164596⟩ Article dans une revue hal-05418247v1
Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors Enora Dolivet,Léopold Gaichies,Corinne Jeanne,Céline Bazille,Mélanie Briandet al. International Journal of Molecular Sciences, 2023, International Journal of Molecular Sciences, 24 (21), pp.16016. ⟨10.3390/ijms242116016⟩ Article dans une revue hal-04481385v1
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma Weijia Cai,Mai Q Nguyen,Nicole A Wilski,Timothy J Purwin,Mégane Vernonet al. Cancer Research, 2022, 82 (14), pp.2625-2639. ⟨10.1158/0008-5472.CAN-21-3217⟩ Article dans une revue hal-05418288v1
The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels Anaïs Wambecke,Mohammad Ahmad,Pierre‐marie Morice,Bernard Lambert,Louis‐bastien Weiswaldet al. Molecular Oncology, 2021, Mol Oncol, 15 (12), pp.3659-3678. ⟨10.1002/1878-0261.13045⟩ Article dans une revue inserm-05418234v1
Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects Matthieu Meryet-Figuiere,Mégane Vernon,Mamy Andrianteranagna,Bernard Lambert,Célia Brochenet al. Cancers, 2021, 13 (16), pp.3970. ⟨10.3390/cancers13163970⟩ Article dans une revue hal-05418298v1
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids Mégane Vernon,Bernard Lambert,Matthieu Meryet-Figuière,Emilie Brotin,Louis-Bastien Weiswaldet al. Molecular Cancer Therapeutics, 2020, 19 (7), pp.1506-1519. ⟨10.1158/1535-7163.MCT-19-0510⟩ Article dans une revue hal-05411088v1
Updates and current challenges in microRNA research for personalized medicine in ovarian cancer Victoria Mandilaras,Mégane Vernon,Matthieu Meryet-Figuière,Katherine Karakasis,Bernard Lambertet al. Expert Opinion on Biological Therapy, 2017, 17 (8), pp.927-943. ⟨10.1080/14712598.2017.1340935⟩ Article dans une revue inserm-02091422v1
Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy Nicolas Vigneron,Matthieu Meryet-Figuière,Audrey Guttin,Jean-Paul Issartel,Bernard Lambertet al. Molecular Oncology, 2016, 10 (7), pp.981-992. ⟨10.1016/j.molonc.2016.03.005⟩ Article dans une revue inserm-02304791v1

Poster de conférence (3)

Development of bioprinted 3D models of glioblastoma M. Vernon,N. Pasquet,Myriam Bernaudin,S. Valable VPH2020 Conference, Aug 2020, e-congrès, France Poster de conférence hal-03167512v1
Development of bioprinted 3D models of glioblastoma Mégane Vernon,Nolwenn Pasquet,Bernaudin Myriam,Valable Samuel Journée Normande de Recherche Biomédicale, JNRb, Nov 2019, Caen, France Poster de conférence hal-02318582v1
Development of bioprinted 3D models of glioblastoma Mégane Vernon,Nolwenn Pasquet,Bernaudin Myriam,Valable Samuel LARC Neurosciences, Oct 2019, Nantes, France Poster de conférence hal-02318573v1